Stock Rich List
#2845 on the rich list of 14,644 insiders

Christopher Peetz

CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals; Director at Arcutis Biotherapeutics. Based in Foster City, California.

$42.8M
in disclosed stock, +$1.0M (+2.47%) today
Live prices, last trade 3:08 PM ET
Rank
2845th of 14,644
Companies held
2
Largest holding
MIRM, 87.8% of total
Latest SEC filing
Nov 4, 2026

What the $42.8M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Mirum Pharmaceuticals MIRM
Common Stock
Directly206,637$95.33$19.7M46.0%Form 4, Nov 4, 2026
Mirum Pharmaceuticals MIRM
Common Stock
Through The Peetz Family Trust187,500$95.33$17.9M41.8%Form 4, Nov 4, 2026
Arcutis Biotherapeutics ARQT
Common Stock
Through The Peetz Family Trust187,500$27.16$5.1M11.9%Form 4, Jul 15, 2026
Arcutis Biotherapeutics ARQT
Common Stock
Directly4,315$27.16$117K0.3%Form 4, Jul 15, 2026

Share counts are the amounts Christopher Peetz reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 4, 2026SoldMIRM20,000$90.00$1.8MView
Sep 1, 2026SoldMIRM8,312$98.08$815KView
Sep 1, 2026SoldMIRM21,688$98.91$2.1MView
Aug 10, 2026SoldMIRM6,017$99.25$597KView
Aug 10, 2026SoldMIRM11,683$98.51$1.2MView
Aug 10, 2026SoldMIRM2,300$100.14$230KView
Jul 6, 2026SoldMIRM12,134$121.65$1.5MView
Jul 6, 2026SoldMIRM4,181$122.34$512KView
Jul 6, 2026SoldMIRM1,710$124.79$213KView
Jul 6, 2026SoldMIRM1,975$123.74$244KView
Jun 1, 2026SoldMIRM883$99.66$88KView
Jun 1, 2026SoldMIRM1,021$98.20$100KView
Jun 1, 2026SoldMIRM1,973$97.56$192KView
Jun 1, 2026SoldMIRM6,926$96.15$666KView
Jun 1, 2026SoldMIRM16,595$95.34$1.6MView
Jun 1, 2026SoldMIRM2,602$94.64$246KView
Mar 16, 2026SoldMIRM40,985$91.98$3.8MView
Feb 2, 2026SoldMIRM9,108$103.30$941KView
Jan 26, 2026SoldMIRM6,831$96.19$657KView
Jan 22, 2026SoldMIRM7,098$93.33$662KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
2842Scott J. Vassalluzzo
Director, Cimpress. Boca Raton, FL
$42.9M−$1.4M (−3.19%)
2843Stuart J. Zimmer
Director, Ategrity Specialty Insurance Company. New York, NY
$42.9M−$389K (−0.90%)
2844Chris M. Calcaterra
Chief Operating Officer, Glaukos. San Clemente, CA
$42.8M+$459K (+1.08%)
2845Christopher Peetz
CHIEF EXECUTIVE OFFICER, Mirum Pharmaceuticals. Foster City, CA
$42.8M+$1.0M (+2.47%)
2846Gautam Patel
Director, Amneal Pharmaceuticals. Bridgewater, NJ
$42.8M−$1.2M (−2.77%)
2847M. Troy Woods
Director, Global Payments. Atlanta, GA
$42.7M−$913K (−2.09%)
2848Robert W. Johnson
Director, Viasat. Carlsbad, CA
$42.7M−$2.7M (−5.92%)

Other Mirum Pharmaceuticals insiders

All MIRM insiders

Questions

How much stock does Christopher Peetz own?

Christopher Peetz holds $42,781,817 in listed stock based on SEC filings and current prices, mostly Mirum Pharmaceuticals (MIRM). That ranks 2845th on the Stock Rich List.

Is this Christopher Peetz's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Christopher Peetz last buy or sell stock?

The most recent open-market trade on file is a sale of 20,000 MIRM shares on Nov 4, 2026 at $90.00.